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Family Physician Involvement in Cancer 
Care Follow-up: The Experience of a Cohort 
of Patients With Lung Cancer 
ABSTRACT 
PURPOSE There has been little research describing the involvement of family 
physicians in the follow-up of patients with cancer, especially during the primary 
treatment phase. We undertook a prospective longitudinal study of patients with 
lung cancer to assess their family physician’s involvement in their follow-up at the 
different phases of cancer. 
METHODS In 5 hospitals in the province of Quebec, Canada, patients with a 
recent diagnosis of lung cancer were surveyed every 3 to 6 months, whether 
they had metastasis or not, for a maximum of 18 months, to assess aspects of 
their family physician’s involvement in cancer care. 
RESULTS Of the 395 participating patients, 92% had a regular family physician 
but only 60% had been referred to a specialist by him/her or a colleague for 
the diagnosis of their lung cancer. A majority of patients identifi ed the oncol-
ogy team or oncologists as mainly responsible for their cancer care throughout 
their cancer journey, except at the advanced phase, where a majority attributed 
this role to their family physician. At baseline, only 16% of patients perceived a 
shared care pattern between their family physician and oncologists, but this pro-
portion increased with cancer progression. Most patients would have liked their 
family physician to be more involved in all aspects of cancer care. 
CONCLUSIONS Although patients perceive that the oncology team is the main 
party responsible for the follow-up of their lung cancer, they also wish their fam-
ily physicians to be involved. Better communication and collaboration between 
family physicians and the oncology team are needed to facilitate shared care in 
cancer follow-up. 
Ann Fam Med 2010;8:526-532. doi:10.1370/afm.1171. 
INTRODUCTION 
Many authors have recognized the lack of continuity in cancer care.1-9 Patients with cancer often need to consult many health professionals from multiple settings, leading to fragmented care. 
At the treatment phase, family physicians may lose track of their patients 
with cancer, who are usually followed by oncology teams. It may be dif-
ﬁ cult for family physicians to take over their patients’ follow-up at the end 
of treatments if they have not seen them for a long time.10-16 
Many health authorities promote collaboration of oncology teams with 
family physicians to keep them in the loop at all phases of cancer.9,17-19 
Little is known on actual family physicians’ practices in cancer care, how-
ever. Norman et al12 have described 3 patterns of care with increasing lev-
els of family physician involvement: (1) sequential, with virtually no family 
physician involvement and patients receiving most of their care from the 
oncology team, (2) parallel, with the family physician still involved but 
mainly for noncancer problems, and (3) shared, with involvement of both 
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the family physician and the oncology team in cancer 
care. Information on family physician patterns of care 
throughout the cancer care trajectory is scarce. This 
study aimed to describe the actual and expected role 
of family physicians at the different phases of cancer, 
among a cohort of patients with lung cancer. 
METHODS 
Study Design and Patient Selection 
We conducted a prospective longitudinal descrip-
tive study between May 2005 and July 2008 among 
patients with lung cancer from 5 hospitals in the Cana-
dian province of Quebec. Patients were eligible if they 
had received a diagnosis of any type of lung cancer, 
regardless of stage and treatment. We chose this spe-
ciﬁ c cancer because of its high prevalence in men and 
women, its variable evolution depending on the cellular 
type and staging at diagnosis, and its diverse treat-
ments. Given these attributes, lung cancer provides the 
opportunity to document, from the patient’s perspec-
tive, the change in their family physician’s involvement 
when they move from one cancer phase to another, 
while following them over a certain period of time.
Eligible patients were informed of the study by 
the oncology team. Those who agreed to be con-
tacted by the research team were invited to partici-
pate and signed an informed consent form. We kept 
basic information on nonparticipants to compare 
them with participants. The study was approved by 
the Research Ethics Committee of Laval University 
and of all study hospitals. 
Data Collection and Study Instruments 
At baseline, patients participated in an interview last-
ing approximately 45 minutes, either at the oncology 
clinic or at their home, depending on their preference. 
They completed questionnaires regarding their social 
and demographic characteristics; lung cancer history; 
functional status according to the Eastern Cooperative 
Oncology Group (ECOG) Performance Status Scale 
(0 = normal activity; 1 = symptoms but ambulatory; 
2 = in bed <50% of time; 3 = in bed ≥50% of time; 
4 = 100% bedridden)20-22; number of visits to the family 
physician in the prior year; family physician’s, special-
ist’s, and oncology team’s responsibility for cancer care; 
family physician’s involvement in their care; perceived 
family physician’s actual and expected roles in vari-
ous aspects of care (coordination, emotional support, 
information transmission, symptom relief); and the 
family physician pattern of care (classiﬁ ed according 
to the previously mentioned categories of Norman et 
al12). We adapted the questionnaire on family physi-
cians’ involvement from the validated primary care 
assessment tools of Safran et al23 and Starﬁ eld et al,24 
and used 4-point Likert scales (1 = not involved; 2 = a 
little involved; 3 = involved; 4 = very involved) that we 
collapsed into dichotomous categories (not involved vs 
involved). We performed a test-retest analysis of this 
instrument on 20 patients, and concordance testing 
showed no statistically signiﬁ cant difference between 
the 2 sets of responses for all variables (P =  .31 to .99). 
We reviewed patients’ medical records to complete 
information related to lung cancer, treatment received, 
and services used. 
Patients were followed up for a maximum of 18 
months. To take into account variability in patients’ 
survival, we reassessed those with metastasis at 
3-month intervals (maximum of 7 interviews) and those 
without metastasis at 6-month intervals (maximum of 
4 interviews). Subsequent interviews lasted 20 to 30 
minutes and took place at the oncology clinic, at home, 
or by telephone, depending on patients’ preference. 
Each time, patients completed the same questionnaires 
on the number of visits to their family physician since 
the last interview, actual and expected family physician 
role in the same aspects of care, and the family physi-
cian pattern of care. 
We reviewed their medical records each time to 
determine if metastasis had developed and to ascertain 
the cancer phase: primary treatment, stability (primary 
treatment completed and no sign of cancer progression 
or new metastasis), progression/relapse, or advanced/
terminal. Determination of all phases of cancer was 
based on medical information from the records, except 
for the advanced/terminal phase, which was deﬁ ned as 
having a score of 3 or 4 on the ECOG scale. We used 
this approach to avoid misclassiﬁ cation of patients, 
considering the lack of consensus in the literature on 
deﬁ ning this cancer phase from clinical predictors. 
Analyses 
We conducted statistical tests on means (t tests) and 
proportions (χ2 tests) to compare participants with 
nonparticipants on their personal and medical charac-
teristics. Patients’ perceptions regarding their family 
physician’s role and pattern of care are presented for 
each cancer phase. When patients were questioned 
more than once per phase (ie, if they had an extended 
period of treatment or there was no progression of 
cancer over time), a single response per patient per 
phase was used in the analyses. 
For continuous variables, we calculated a mean score 
from all responses provided by a patient per phase, 
for each variable, and used this score in analyses. For 
categorical variables (eg, family physician pattern of 
care for which the 4 categories—no family physician, 
sequential, parallel, and shared care—represent an 
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increasing level of family physician involvement), we 
conducted analyses alternatively using either the high-
est or the lowest score as the sole response per patient 
per phase. Since we found the results to be equivalent 
using either of those scores, we arbitrarily decided to 
present results obtained with the highest score. Nota-
bly, in most of these cases, patients questioned repeat-
edly in a cancer phase reported the same pattern of 
family physician involvement over time. 
We used the Cochran-Mantel-Haenszel test to 
assess the variation, with the cancer phases, of patients’ 
perceptions regarding their family physician’s involve-
ment in cancer care and the family physician pattern of 
care. Analyses of variance were performed to compare, 
at each phase, the mean number of visits to the family 
physician according to pattern of care. An α level of 
.05 was used as the signiﬁ cance threshold. All statisti-
cal analyses were performed using SAS software, ver-
sion 9.1 (SAS Institute Inc, Cary, North Carolina). 
RESULTS 
Patient Disposition and Characteristics 
Of the 695 eligible patients with lung cancer, 395 were 
recruited for a participation rate of 56.8%. Figure 1 
shows patients’ participation at each cancer phase. 
Over the 18-month follow-up, individual patients’ 
courses varied considerably; in fact, we found 15 sce-
narios of evolution from one phase to another. For 
example, 52 (13.2%) of the patients continued receiv-
ing treatment during the whole study, 192 (48.6%) 
remained in the stability phase throughout the follow-
up, and 20 (5.1%) went directly from diagnosis to the 
progression/relapse or advanced/terminal phases. 
Overall, 148 (37.5%) of the patients died during 
the study, and 44 (11.1%) withdrew, mainly because 
their condition was worsening and they were over-
whelmed after receiving the bad news. Also, because 
of the slow recruitment pace, we extended the recruit-
ment period 6 months longer than originally planned, 
but the last 95 recruited patients were followed up for 
only 12 months. 
There was no difference according to type of 
lung cancer between participants and nonparticipants 
(P = .50). More women than men declined the invita-
tion to participate (P = .05). In addition, participants 
were slightly younger on average than nonparticipants 
(63.4 vs 65.5 years; P = .02).
Patients’ personal and medical characteristics at 
baseline are presented in Table 1. Women were signiﬁ -
cantly younger than men (61.7 vs 64.7 years; P = .002) 
and more frequently lived alone (30.6% vs 19.9%; 
P = .01). Most patients had been aware of their diagno-
sis for almost 3 months on average. A large proportion 
of patients (63.4%) had positive lymph nodes at diag-
nosis, and a cumulative 42% had metastases at some 
point between diagnosis and the end of the 18-month 
follow-up. Almost all patients (92.9%) were offered 
a treatment. At baseline, nearly one-third (30.6%) of 
patients had been hospitalized at least once in rela-
tion to their lung cancer, excluding the 75 patients 
who were hospitalized for a lung surgery. Only 16.7% 
of patients had visited the emergency department for 
reasons related to their lung cancer, and the majority 
of patients (77%) reported being assisted in their care 
trajectory by a nurse navigator. 
 Figure 1. Patient participation in the study. 
Primary treatment phase: n = 118 
 52 Stayed at this phase
 6 Withdrew  
 29 Died 
Median duration of 6 months  
Stability phase: n = 238  
 192 Stayed at this phase
 11 Withdrew
 38 Died
Median duration of 12 months  
Progression/relapse phase: n = 50 
 37 Stayed at this phase  
 1 Withdrew
 2 Died
Median duration of 6 months
Advanced/terminal phase: n = 39  
 9 Stayed at this phase 
 1 Withdrew
 29 Died
Median duration of 3 months 
695 Eligible patients 
395 Patients recruited at baseline 
(Diagnosis phase)  
25 Withdrew
50 Died
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Involvement of Family Physicians 
in Patients’ Cancer Care 
A total of 364 patients (92.1%) reported having a regu-
lar family physician. Among the 31 patients who did 
not have one, the majority, 19 (61.3%), wanted to ﬁ nd 
one, but 12 believed that they should be followed by 
specialists. Approximately two-thirds of patients had 
been followed by the same family physician for more 
than 5 years and, on average, they had consulted him/
her 4 times in the prior year (4.0 ± 4.5; range 0-52). 
Overall, many patients were unaware of their family 
physician’s practice regarding home care (48.4%) and 
after-hours care (20.6%). 
Approximately 60% of patients were referred by 
their family physician or a colleague from the same clinic 
to conﬁ rm the diagnosis of lung cancer; the remain-
ing 40% were referred either by a physician from the 
emergency department (18%) or by a specialist (22%). 
In most cases (80.3%), the family physician assisted 
patients in making the appointment with the specialist. 
Among patients referred by other physicians, the large 
majority (83.1%) reported that their family physician 
was informed of their diagnosis. Most patients reported 
being satisﬁ ed with the time their family physician gave 
for discussion (93%) and with his or her patience in 
responding to questions (93%), ability to make them at 
ease (96%), and ability to reassure them (88%). 
A large proportion of patients continued to see 
their family physician throughout their cancer journey, 
but predominantly after the end of treatment when 
their condition was stable (88%) (P <.001) (Table 2). 
At all phases of cancer, a majority of patients reported 
that they discussed with their family physician their 
visits to the oncology team, but no more than half of 
Table 1. Patient Characteristics at Baseline (N = 395)
Characteristic





Functional status  
Normal activity 178 (45.1)
Symptoms but ambulatory 150 (37.9)
Confi ned to bed or chair 
<50% of waking hours 
44 (11.1)
Confi ned to bed or chair 





Type of lung cancer  
Squamous cell carcinoma 77 (19.5)
Adenomatous carcinoma 164 (41.5)
Other non–small cell carcinoma 67 (17.0)






Chemotherapy and/or radiation 
therapy 
254 (64.3)
No treatment 28 (7.1)
Metastases  
Present at baseline 128 (32.4)
Found during follow-up 37 (9.4)
None 230 (58.2)
Cancer stage  
Stage I 56 (14.2)
Stage II 33 (8.3)
Stage III 119 (30.1)
Stage IV 133 (33.7)
Not confi rmed 54 (13.7)
Age, years 63.4 ± 9.5 (31-88) [64]
Education, years 10.9 ± 3.9 (2-24) [11]
Intervals in care  
Investigation to diagnosis, weeks 5.6 ± 8.0 (0-78) [3]
Diagnosis to fi rst treatment, days 29.0 ± 26.6 (0-140) [21]
Table 2. Extent of Family Physician Involvement 
by Cancer Phase
Extent of Involvement
N (% of 
Patients) P Valuea
Contact with family physician   
Diagnosis 364 (58.8) <.001




If contact with family physician, dis-
cussion about visits to oncologist
  
Diagnosis 214 (72.9) .09




Questions to ask of family physician 
in relation to cancer
  
Diagnosis 214 (32.7) <.001












a From the Cochran-Mantel-Haenszel test; compares, across cancer phases, the 
proportion of patients who reported each extent of family physician involvement. 
b Only for patients who had treatment. 
c This question was not asked at the diagnosis phase; often, treatment had 
already begun at the baseline interview.
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patients had additional questions to ask to their fam-
ily physician in relation to their lung cancer, except 
at the advanced/terminal phase, where this situation 
was more common (64%) (P <.001). Similarly, at most 
cancer phases except the advanced/terminal one, 
few patients reported that their family physician was 
involved in decisions regarding cancer treatment. 
Actual and Expected Family Physician 
Involvement in Cancer Care 
Although family physicians contributed modestly to 
cancer care follow-up, most patients were satisﬁ ed 
in general with their family physician’s involvement. 
Nevertheless, when questioned on speciﬁ c aspects 
of cancer care, there was a signiﬁ cant gap between 
patients’ perception of the actual involvement of their 
family physician and their expectations regarding his/
her contribution in coordination of care, emotional 
support, information transmission, and symptom relief 
(Table 3). At all phases of cancer, most patients would 
have liked their family physician to be more involved 
than he/she actually was in all these aspects of care 
(P <.05). 
Table 4 shows patients’ perception of their family 
physician’s pattern of care at the different phases of 
cancer. Although the proportion of patients without 
a regular physician did not vary signiﬁ cantly with the 
evolution of cancer, the 3 other patterns of care dif-
fered from diagnosis to the advanced/terminal phase. 
Parallel care was the most frequent pattern reported at 
all phases of cancer, except at the advanced/terminal 
phase, where shared care was identiﬁ ed more often. 
At diagnosis, patients reported a mean number of 
visits to their family physician in the prior year that 
was signiﬁ cantly different according to their perceived 
family physician’s pattern of care (P <.001). In particu-
lar, there was increasing family physician involvement 
from the sequential pattern of care (2.4 ± 2.5 visits) to 
the parallel pattern of care (3.9 ± 3.6), and also from 
the parallel to the shared care pattern (5.6 ± 7.3). The 
same difference was consistently seen between the 
patterns of care at all other cancer phases (Table 5). 
Finally, when asked independently for each type 
of health care professional, more than 90% of patients 
considered oncologists to be the main professionals 
responsible for their cancer care at all phases but one. 
The exception was the advanced phase, where more 
than 70% patients gave this responsibility to their fam-
ily physician. 
Table 4. Family Physician Pattern of Care by Cancer Phase













No family physician 7.8 8.5 4.2 4.0 5.1 .31
Sequential 11.6 12.7 3.8 2.0 18.0 <.001
Parallel 64.6 54.2 55.9 62.0 23.1 <.001
Shared 16.0 24.6 36.1 32.0 53.8 <.001
Note: Values are percentages of patients.  
a From the Cochran-Mantel-Haenszel test; compares variation of each family physician pattern of care across cancer phases.
Table 3. Family Physician Involvement in Various 












Coordination of care    
Diagnosis 357 (41.2) 362 (83.4) <.001
Primary treatment 102 (24.5) 107 (83.2) <.001
Stability 227 (31.3) 228 (85.1) <.001
Progression/
relapse 
46 (37.0) 48 (75.0) <.001
Advanced/terminal 37 (46.0) 37 (86.5) <.001
Emotional support    
Diagnosis 351 (36.8) 362 (83.4) <.001
Primary treatment 104 (44.2) 107 (86.9) <.001
Stability 227 (54.6) 228 (88.2) <.001
Progression/relapse 46 (60.9) 48 (87.5) .002
Advanced/terminal 37 (51.4) 37 (81.1) .007
Transmission of 
information
   
Diagnosis 352 (17.3) 362 (62.0) <.001
Primary treatment 103 (18.4) 107 (59.8) <.001
Stability 227 (29.1) 228 (72.4) <.001
Progression/
relapse 
46 (34.8) 48 (58.3) .01
Advanced/terminal 37 (37.8) 37 (73.0) .002
Symptom relief    
Diagnosis 332 (13.0) 361 (62.3) <.001
Primary treatment 100 (19.0) 107 (74.8) <.001
Stability 225 (30.2) 228 (79.8) <.001
Progression/relapse 46 (30.4) 48 (72.9) <.001
Advanced/terminal 37 (43.2) 37 (78.4) .002
a From the χ2 test; compares, at each cancer phase, the actual vs expected pro-
portions for family physician involvement in specifi c aspects of cancer care, as 
reported by patients.
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DISCUSSION 
This study provides new knowledge regarding family 
physicians’ actual and expected involvement in cancer 
care, as no other longitudinal study has looked at these 
physicians’ role throughout the cancer care trajectory, 
to the best of our knowledge. Recently, Cheung et 
al25 have documented patients’ expectations regarding 
some aspects of cancer follow-up speciﬁ cally for survi-
vorship care. This latter study complements our results 
by also providing a comparison of patients’ expecta-
tions to the ones of family physicians and oncologists. 
But their study was cross-sectional and limited to 
cancer survivorship care, compared with ours, which 
addressed the evolution of patients’ expectations from 
diagnosis to the advanced/terminal phase of cancer. 
In our cohort, most patients reported having a 
regular family physician, a ﬁ nding that is concordant 
with ﬁ ndings from other studies with patients of simi-
lar age.16,26 Throughout the cancer care trajectory, 
less than 50% of patients reported a high degree of 
family physician involvement in most aspects of can-
cer care. These physicians were least involved during 
the primary treatment phase of cancer, as reported by 
patients. This study thus conﬁ rms that family physi-
cians are largely cut off from cancer care during the 
treatment phase, as has been found in other studies.10,16 
From diagnosis to the progression phase, the pattern 
of care most frequently reported was the parallel one, 
which corresponds to some family physician involve-
ment in follow-up, but mainly for noncancer health 
problems. Shared care between family physicians and 
the oncology team was mentioned increasingly as the 
cancer progressed, and became the most frequent pat-
tern of care at the advanced/terminal phase. These 
results are consistent with ﬁ ndings of Sisler et al,16 but 
they provide additional information by documenting 
the change in pattern of care during the cancer care tra-
jectory. They seem to reﬂ ect patients’ preference for a 
shift in care toward specialists after 
the diagnosis of cancer until they 
reach the advanced phase of their 
disease, at which point a substantial 
proportion turn back to their family 
physician. In that sense, the parallel 
pattern of care may be perceived by 
patients as providing better-deﬁ ned 
roles for both family physicians 
and oncologists, compared with a 
shared pattern of care that requires 
good communication between phy-
sicians to determine how best to 
interface with each other in deliver-
ing care to patients. These ﬁ ndings 
may also explain why a majority 
of patients were satisﬁ ed with their family physician’s 
overall level of involvement, even though few of them 
reported a high level of family physician involvement 
in their cancer care. Nevertheless, as Cheung et al25 
concluded, the respective roles expected of family phy-
sicians and oncologists need to be clariﬁ ed in order to 
provide continuous and integrated cancer care. 
Despite patients’ high degree of satisfaction with 
their family physician’s level of involvement overall, 
there was a signiﬁ cant gap, at all phases of cancer, 
between their perception of their family physician’s 
actual follow-up and what they expected from them in 
speciﬁ c aspects of cancer care. These contrasting results 
emphasize the importance of assessing speciﬁ c domains 
of satisfaction. The gap found between patients’ experi-
ences and expectations mirrors ﬁ ndings of Miedema et 
al,27 which showed that 80% of surveyed cancer patients 
wanted counseling from their family physician about the 
emotional issues of cancer, but only 20% received it. 
There are some limitations to this study. First, the 
rather low participation rate combined with the high 
dropout rate may raise some concerns. But these rates 
compare well with those of other studies conducted 
with such a vulnerable population.16,25,28 Moreover, the 
withdrawal rate was quite low in this cohort, the main 
reasons for dropping out being death or cancer recur-
rence associated with poor functional status, which 
were inevitable in this population. Second, because 
the study was limited to patients with lung cancer, it 
is uncertain if results may be generalized to patients 
with other types of cancer. Since the cohort included 
patients varied in age, sex, stage at diagnosis, and treat-
ments received, however, it gives insights into patients’ 
preferences on cancer follow-up care that may also 
apply to other cancers. Third, the classiﬁ cation of fam-
ily physician patterns of care relied on patients’ percep-
tion, which may be considered imprecise. Nevertheless, 
there was a signiﬁ cant difference, at baseline and for 
Table 5. Patient Visits to Their Family Physician by Cancer Phase 






Physician Sequential Parallel Shared Care
Primary treatment – 0.00 0.89 ± 1.38 2.25 ± 1.73 <.001
Stability – 0.00 1.28 ± 1.26 2.54 ± 2.52 <.001
Progression/relapse – 0.72 ± 0.00 1.33 ± 1.48 3.21 ± 3.27 .02
Advanced/terminal – 0.67 ± 0.82 1.20 ± 1.81 2.37 ± 1.30 .02
Note: Values are mean ± standard deviation number of visits. 
a Values should not be compared from one cancer phase to another since duration of each phase was not 
equivalent. 
b From analysis of variance; compares, at each cancer phase, the mean number of visits to the family physi-
cian according to family physician patterns of care.
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each cancer phase, in the mean number of patient vis-
its to their family physician according to this pattern 
of care, supporting the validity of this classiﬁ cation 
originally described by Norman et al.12 Finally, our 
ﬁ ndings are based on self-reported data, and they must 
be interpreted with caution given the small number of 
participants in some phases of cancer, particularly at the 
progression/relapse and advanced/terminal phases. 
Despite these limitations, this study provides valu-
able information on how patients with lung cancer 
experience family physicians’ contribution to their care 
and what they expect from them, throughout their 
cancer journey. As highlighted by other authors,10,16,29-31 
this research reinforces the importance of good com-
munication and collaboration between family physicians 
and the oncology team in order to keep the former 
involved at all phases of cancer and to promote shared 
care in cancer follow-up. Future research should focus 
on developing and evaluating innovative strategies to 
increase interprofessional collaboration to ultimately 
improve continuity of care for patients with cancer. 
To read or post commentaries in response to this article, see it 
online at http://www.annfammed.org/cgi/content/full/8/6/526. 
Key words: Cancer care; family physicians; primary care; patient care; 
patient care team; multidisciplinary communication; collaboration; conti-
nuity of care; cancer follow-up 
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